** LC Bead LUMITM is the official trademark of BTG (Biocompatibles UK Ltd.) and is not available as part of Philips’ OncoSuite.
[1] Stewart, BW, Wild CW. World Cancer Report. 2014. Available at: https://shop.iarc.fr/products/wcr2014 Accessed August 2016
[2] Tucker, ME. Fatty Liver Disease Surging as Liver Cancer Cause. 2015. Available at: http://www.medscape.com/viewarticle/843733 Accessed August 2016
[3] Loffroy R, et al. Intraprocedural C-arm dual-phase cone-beam CT: can it be used to predict short-term response to TACE with drug-eluting beads in patients with hepatocellular carcinoma? Radiol. 2013 Feb;266(2):636-48
Ad Statistics
Times Displayed: 21862
Times Visited: 433 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
[4] Miyayama S, et al. Efficacy of automated tumor-feeder detection software using cone-beam computed tomography technology in transarterial embolization through extrahepatic collateral vessels for malignant hepatic tumors. Hepatol Res. 2016 Feb;46(2):166-73
[5] Schernthaner RE, et al. Improved Visibility of Metastatic Disease in the Liver During Intra-Arterial Therapy Using Delayed Arterial Phase Cone-Beam CT. Cardiovasc Intervent Radiol. 2016 Jul 5. [Epub ahead of print]
[6] Schernthaner RE, et al. Feasibility of a modified cone-beam CT rotation trajectory to improve liver periphery visualization during transarterial chemoembolization. Radiology. 2015;277(3):833–41
[7] Levy EB, et al. First Human Experience with Directly Image-able Iodinated Embolization Microbeads. Cardiovasc Intervent Radiol. 2016 Aug;39(8):1177-86
Back to HCB News
